160 related articles for article (PubMed ID: 12709332)
21. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia.
Tessier PR; Kim MK; Zhou W; Xuan D; Li C; Ye M; Nightingale CH; Nicolau DP
Antimicrob Agents Chemother; 2002 May; 46(5):1425-34. PubMed ID: 11959578
[TBL] [Abstract][Full Text] [Related]
22. In vivo pharmacodynamics of lefamulin, the first systemic pleuromutilin for human use, in a neutropenic murine thigh infection model.
Wicha WW; Craig WA; Andes D
J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii5-iii10. PubMed ID: 30949706
[TBL] [Abstract][Full Text] [Related]
23. In vivo pharmacodynamic activity of daptomycin.
Safdar N; Andes D; Craig WA
Antimicrob Agents Chemother; 2004 Jan; 48(1):63-8. PubMed ID: 14693519
[TBL] [Abstract][Full Text] [Related]
24. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
Kim MK; Zhou W; Tessier PR; Xuan D; Ye M; Nightingale CH; Nicolau DP
Antimicrob Agents Chemother; 2002 Oct; 46(10):3185-92. PubMed ID: 12234843
[TBL] [Abstract][Full Text] [Related]
25. In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model.
Fukuda Y; Yanagihara K; Ohno H; Higashiyama Y; Miyazaki Y; Tsukamoto K; Hirakata Y; Tomono K; Mizuta Y; Tashiro T; Kohno S
Antimicrob Agents Chemother; 2006 Jan; 50(1):121-5. PubMed ID: 16377676
[TBL] [Abstract][Full Text] [Related]
26. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model.
Xuan D; Zhong M; Mattoes H; Bui KQ; McNabb J; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 2001 Mar; 45(3):794-9. PubMed ID: 11181363
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations.
Nicolau DP; Onyeji CO; Zhong M; Tessier PR; Banevicius MA; Nightingale CH
Antimicrob Agents Chemother; 2000 May; 44(5):1291-5. PubMed ID: 10770764
[TBL] [Abstract][Full Text] [Related]
28. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
Lepak AJ; Andes DR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
Zhanel GG; Roberts D; Waltky A; Laing N; Nichol K; Smith H; Noreddin A; Bellyou T; Hoban DJ
J Antimicrob Chemother; 2002 May; 49(5):807-12. PubMed ID: 12003975
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model of infection.
MacGowan AP; Rogers CA; Holt HA; Wootton M; Bowker KE
Antimicrob Agents Chemother; 2001 Oct; 45(10):2916-21. PubMed ID: 11557490
[TBL] [Abstract][Full Text] [Related]
31. In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.
Craig WA; Andes DR
Antimicrob Agents Chemother; 2008 Oct; 52(10):3492-6. PubMed ID: 18676887
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
Xiao XM; Xiao YH
Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae.
Lepak AJ; Zhao M; Liu Q; Wang P; Wang Y; Bader JC; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559140
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication.
Lister PD
Antimicrob Agents Chemother; 2002 Jan; 46(1):69-74. PubMed ID: 11751113
[TBL] [Abstract][Full Text] [Related]
35. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
[TBL] [Abstract][Full Text] [Related]
36. Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacin.
MacGowan A; Rogers C; Holt HA; Wootton M; Bowker K
J Antimicrob Chemother; 2000 Jul; 46(1):73-8. PubMed ID: 10882692
[TBL] [Abstract][Full Text] [Related]
37. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.
Takahata M; Yamada H; Morita T; Furubou S; Minami S; Todo Y; Watanabe Y; Narita H
Antimicrob Agents Chemother; 2002 Jun; 46(6):1760-5. PubMed ID: 12019087
[TBL] [Abstract][Full Text] [Related]
39. Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.
Rodriguez-Cerrato V; McCoig CC; Saavedra J; Barton T; Michelow IC; Hardy RD; Bowlware K; Iglehart J; Katz K; McCracken GH
Antimicrob Agents Chemother; 2003 Jan; 47(1):211-5. PubMed ID: 12499193
[TBL] [Abstract][Full Text] [Related]
40. The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae.
Ambrose PG; Grasela DM
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):151-7. PubMed ID: 11109013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
